Evidence map›Paper›PMID 34830943›Full record

ArticleCancers2021

A Multiparametric MR-Based RadioFusionOmics Model with Robust Capabilities of Differentiating Glioblastoma Multiforme from Solitary Brain Metastasis.

Jialiang Wu, Fangrong Liang, Ruili Wei, Shengsheng Lai, Xiaofei Lv, Shiwei Luo, Zhe Wu, Huixian Chen, Wanli Zhang, Xiangling Zeng and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jialiang WuDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.ORCID 0000-0003-3660-2487
Fangrong LiangSchool of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.ORCID 0000-0003-4657-9145
Ruili WeiDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Shengsheng LaiSchool of Medical Equipment, Guangdong Food and Drug Vocational College, Guangzhou 510520, China.
Xiaofei LvState Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Shiwei LuoDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Zhe WuDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Huixian ChenDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Wanli ZhangDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Xiangling ZengDepartment of Radiology, Huizhou Municipal Central Hospital, Huizhou 516001, China.
Xianghua YeDepartment of Radiation Oncology, 1st Affiliated Hospital, Zhejiang University, Hangzhou 310009, China.
Yong WuDepartment of Oncology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Xinhua WeiDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Xinqing JiangDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Xin ZhenSchool of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.
Ruimeng YangDepartment of Radiology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.ORCID 0000-0003-2768-9429

Funding

the Guangzhou Key Laboratory of Molecular Imaging and Clinical Translational Medicine and the Construction of High-level Key Clinical Specialty (Medical Imaging) in Guangzhou. nonethe National Natural Science Foundation of China 81971574, 81874216the Natural Science Foundation of Guangdong Province, P.R. China 2018A030313282, 2021A1515011350the Science and Technology Project of Guangzhou, P.R. China 201904010422, 202002030268, 202102010025
6 · The paper itself

Abstract

This study aimed to evaluate the diagnostic potential of a novel RFO model in differentiating GBM and SBM with multiparametric MR sequences collected from 244 (131 GBM and 113 SBM) patients. Three basic volume of interests (VOIs) were delineated on the conventional axial MR images (T

Indexed as

fusionglioblastoma multiformeMRIradiomicssolitary brain metastasis

Identifiers

PMID34830943
PMCPMC8616314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.